NO923266L - Heksahydrobenzo(f)quinolinoner - Google Patents

Heksahydrobenzo(f)quinolinoner

Info

Publication number
NO923266L
NO923266L NO92923266A NO923266A NO923266L NO 923266 L NO923266 L NO 923266L NO 92923266 A NO92923266 A NO 92923266A NO 923266 A NO923266 A NO 923266A NO 923266 L NO923266 L NO 923266L
Authority
NO
Norway
Prior art keywords
hexahydrobenzo
quinolinoner
quinolin
steroid
alpha
Prior art date
Application number
NO92923266A
Other languages
English (en)
Norwegian (no)
Other versions
NO923266D0 (no
Inventor
Kenneth Steven Hirsch
Charles David Jones
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO923266D0 publication Critical patent/NO923266D0/no
Publication of NO923266L publication Critical patent/NO923266L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
NO92923266A 1991-08-21 1992-08-20 Heksahydrobenzo(f)quinolinoner NO923266L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74813491A 1991-08-21 1991-08-21
US07/780,166 US5250539A (en) 1991-08-21 1991-10-21 Hexahydrobenzo[f]quinolinones

Publications (2)

Publication Number Publication Date
NO923266D0 NO923266D0 (no) 1992-08-20
NO923266L true NO923266L (no) 1993-02-22

Family

ID=27114886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923266A NO923266L (no) 1991-08-21 1992-08-20 Heksahydrobenzo(f)quinolinoner

Country Status (17)

Country Link
US (1) US5250539A (zh)
EP (1) EP0531026B1 (zh)
JP (1) JPH05213889A (zh)
KR (1) KR930004269A (zh)
CN (1) CN1069488A (zh)
AT (1) ATE173467T1 (zh)
AU (1) AU2118292A (zh)
BR (1) BR9203266A (zh)
CA (1) CA2076509A1 (zh)
CZ (1) CZ256792A3 (zh)
DE (1) DE69227612T2 (zh)
FI (1) FI923751A (zh)
HU (1) HUT68064A (zh)
IL (1) IL102880A0 (zh)
MX (1) MX9204815A (zh)
NO (1) NO923266L (zh)
TW (1) TW218011B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU654573B2 (en) * 1991-08-21 1994-11-10 Eli Lilly And Company Benzo(f)quinolinones
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
FR2737721B1 (fr) 1995-08-08 1997-09-05 Roussel Uclaf Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
GB0222516D0 (en) * 2002-09-27 2002-11-06 Karobio Ab Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102046A1 (en) * 1982-08-26 1984-03-07 Schering Corporation Tricyclic lactams, method for making them, pharmaceutical compositions containing them
US4511569A (en) * 1982-08-26 1985-04-16 Schering Corporation Tricyclic lactams and derivatives useful in increasing cardiac contractility
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US5120742A (en) * 1984-02-27 1992-06-09 Merck & Co., Inc. 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
ES2051843T3 (es) * 1987-05-11 1994-07-01 Ono Pharmaceutical Co Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
IN167395B (zh) * 1987-07-21 1990-10-20 Hoffmann La Roche
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors

Also Published As

Publication number Publication date
FI923751A (fi) 1993-02-22
MX9204815A (es) 1993-12-01
EP0531026A1 (en) 1993-03-10
US5250539A (en) 1993-10-05
CA2076509A1 (en) 1993-02-22
IL102880A0 (en) 1993-01-31
DE69227612D1 (de) 1998-12-24
CZ256792A3 (en) 1993-04-14
TW218011B (zh) 1993-12-21
FI923751A0 (fi) 1992-08-20
KR930004269A (ko) 1993-03-22
JPH05213889A (ja) 1993-08-24
BR9203266A (pt) 1993-04-06
AU2118292A (en) 1993-02-25
DE69227612T2 (de) 1999-05-06
EP0531026B1 (en) 1998-11-18
CN1069488A (zh) 1993-03-03
HUT68064A (en) 1995-05-29
ATE173467T1 (de) 1998-12-15
NO923266D0 (no) 1992-08-20

Similar Documents

Publication Publication Date Title
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE3881443D1 (de) Imidazol-verbindung und diese enthaltende biozide zusammensetzungen.
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE69313134D1 (de) Adjuvantien enthaltende impfstoffzusammensetzung
IL105715A0 (en) 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
IL105717A0 (en) 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DZ1559A1 (fr) Compositions pharmaceutiques.
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
KR950701629A (ko) 신규한 탁산 유도체, 그의 제법 및 그를 함유하는 조성물(Novel taxane derivatives, their preparation and compositions containing same)
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
AU1174588A (en) Anticonvulsant agents
HUP9900863A3 (en) 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.